14
Views
1
CrossRef citations to date
0
Altmetric
Review

Integrated health outcomes research strategies in drug or medical device development, pre- and postmarketing: time for change

, , &
Pages 269-278 | Published online: 09 Jan 2014

References

  • Rapier CM. An introduction to Health Outcomes Research. Brookwood Medical Publications Ltd, Surrey, UK (1996).
  • Epstein RS, Sherwood LM. From outcomes research to disease management: a guide for the perplexed. Ann. Intern. Med. 124(9), 832–837 (1996).
  • Drummond M, Dubois D, Garattini L et al Current trends in the use of Pharmacoeconomics and Outcomes Research in Europe. Value in Health 2(5) 323–332 (1999).
  • Lasagna L. A plea for the "Naturalistic Study of Medicines". Eur. j Clin. Pharmacol 7, 153–154 (1974).
  • Downs S, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of healthcare interventions. J. Epidemiol Commun. Health 52,377–384 (1998).
  • Black N. What observational studies can offer decision makers. Horm. Res. 51 (Suppl. 1), 44–49 (1999).
  • Black N. Why we need observational studies to evaluate the effectiveness of healthcare. Br. Med.1 312,1215–1218 (1996).
  • Rothman KJ, Greenland S. Modem epidemiology (second edition). Lippincott-Raven, Philadelphia, USA (1998).
  • Sacket DL, Richardson WS, Rosenberg W, Haynes RB. Is this evidence about a treatment valid? Is this evidence about a treatment important? Can you apply this valid, important evidence about a treatment in caring for your patient? In: Evidence-based Medicine. How to Practice & Teach EBM Churchill Livingston, New York, USA (1997).
  • Benson K, Hartz MD. A comparison of observational studies and randomised controlled trials. N Engl. J. Med. 342, 1878–1886 (2000).
  • Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl. J. Med. 342, 1887–1892 (2000).
  • Ray WA, Griffin MR, Avorn J. Evaluating drugs after their approval for clinical use. N Engl. J. Med. 329,2029–2032 (1993).
  • Paul JE, Trueman P. Fourth hurdle reviews, NICE and database applications. Pharmacoepidemiol Drug Sal: 10(5), 429–438 (2001).
  • World Health Organisation. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1946; signed on 22 July 1946 by the representatives of 61 States. Official Records of the Work/ Health Organization 2,100 (1946).
  • Cooke A. Quality of Health and Medical Information on the Internet. Clin. Performance Qua): Healthcare 7(4), 178–182 (1999).
  • Badia X, Herdman M. The importance of health-related-quality-of-life data in determining the value of drug therapy. Clin. Ther. 23,168–175 (2001).
  • Sander C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised controlled trials: bibliographic studies. Br Med. 317,1191–1194 (1998).
  • Acquadro C. The European Regulatory Issues on Health-Related Quality of Life Assessment (ERIQA) Project: Preliminary Results and Plans for the Future. Qua): Life Newsletter 24,1–3 (2000).
  • Santanello NC, Baker D, Cappelleri JC et al. Regulatory issues for health-related quality of life — phrma health outcomes committee workshop, 1999. Value in Health 5(1), 14–25 (2002).
  • Trueman P, Drummond M, Hutton J. Developing guidance for budget impact analysis. PhannacoEconomks19, 609–621 (2001).
  • Buxton MJ, Drummond MF, Van Hout BA et al. Modelling in economic evaluation: An unavoidable fact of life. Health Econ. 6, 217–227 (1997).
  • Sculper M, Drummond M, Buxton M. The iterative use of economic evaluation as part of the process of health technology assessment.j Health Serv. Res. Policy 2, 26–30 (1997).
  • Barendregt JJ, Bonneux L. The trouble with health economics. Eur. J Public Health 9, 309–312 (1999).
  • Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 282 (15), 1453–1457 (1999).
  • Drummond ME A reappraisal of economic evaluation of pharmaceuticals. Science or marketing? PharmacoEconomics 14(1), 1–9 (1998).
  • Task Force on Principles for Economic Analysis of Healthcare Technology. Economic analysis of healthcare technology. Ann. Intern. Med 122, 61–70 (1995).
  • Guidelines for Economic Evaluation of Pharmaceuticals: Canada. Canadian Office for Health Technology Assessment. 2nd edition (1998).
  • Drummond R, Luft HS. Pharmacoeconomic analyses: making then transparent, making them credible. JAMA 283(16), 2158–2160 (2000).
  • Drummond M. The emerging government requirement for economic evaluation of pharmaceuticals. PharmacoEconomics 6\(Suppl. 1), 42–50 (1994).
  • Drummond MF, Rutten F, Brenna A et al. Economic evaluation of pharmaceuticals: a European perspective. PharmacoEconomics 4(3), 173–186 (1993).
  • Genduso LA. Review of health economic guidelines in the form of regulations, principles, policies, and positions. Drug Information 30, 1003–1016 (1996).
  • McDonald R, Haycox A, Walley T. The impact of health economics on healthcare delivery. The health economists perspective. PharmacoEconomics 19(8), 803–809 (2001).
  • Sacristan JA, Soto J, Galende I, Hylan TR. Randomized database studies: a new method to assess drugs' effectiveness? J Clin. Epidemiol. 51(9), 713–715 (1998).
  • Lloyd A, Grant D. Incorporating Reimbursement Requirements into the Drug Development Process. Spectrum Reimbursement, Pharmacoeconomics, and Disease Management. 10–1 — 10–12 (June 29 2001).
  • Garcia Navarro MD, Orozco Beltran D, Gil Guillén V, Carratald Munuera C, Terol Molt6 C, Merino Sanchez J. Relación entre incumplimiento farmacológico y grado de control en pacientes con hipertensi6n, diabetes o dislipemia. Med. Din. 116, 141–146 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.